Marginum’s technology promotes the effectiveness of cancer surgeons with monitoring techniques that detect tissue fluorescence. Our vision is to create a leading company producing fluorescence spectrum analysis solutions in surgery.
We participated in the Draft program, from which our team won €4,000 to promote our business. The company was founded only after the Draft program.
Business Center’s advice on starting a business was invaluable. In addition, the tips received regarding suitable funding agencies were relevant. The Business Centers contact networks have also been helpful in identifying various networking events. We are very satisfied with our company.
Samu Lehtonen, CEO & Co-Founder
